Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: allopurinol

« Back to Dashboard

Summary for Generic Name: allopurinol

Drug Master File Entries: see list21
Suppliers: see list9
Therapeutic Class:Antigout Agents

Pharmacology for Ingredient: allopurinol

Clinical Trials for: allopurinol

A Pilot Study of Allopurinol As A Modifier of 6-MP Metabolism in Pediatric ALL
Status: Recruiting Condition: Acute Lymphoblastic Leukemia (ALL)

Does ALlopurinol Regress lefT Ventricular Hypertrophy in End Stage REnal Disease: The ALTERED Study
Status: Enrolling by invitation Condition: End Stage Renal Disease; Left Ventricular Hypertrophy

Does Allopurinol Reduce Thickening of the Left Ventricle of the Heart in Patient With Treated Hypertension?
Status: Recruiting Condition: Hypertension; Hypertrophy, Left Ventricular

Allopurinol for Mania: A Randomized Trial Administering Allopurinol vs. Placebo as add-on to Mood Stabilizers and/or Antipsychotics in Patients in a Bipolar Manic Episode
Status: Completed Condition: Mania

The Blood Pressure Effects of Febuxostat in Patients Previously Treated With Allopurinol: A Pilot Study
Status: Terminated Condition: Blood Pressure; Gout

Study of Tranilast Alone or in Combination With Allopurinol in Subjects With Hyperuricemia
Status: Completed Condition: Gout; Hyperuricemia

Allopurinol in Acute Coronary Syndrome
Status: Recruiting Condition: Chronic Stable Angina

Allopurinol Outcome Study
Status: Completed Condition: Gout

Allopurinol in Schizophrenia: A Randomized Trial Administering Allopurinol vs Placebo as add-on Antipsychotics in Patients With Schizophrenia
Status: Completed Condition: Schizophrenia; Schizoaffective Disorder

Allopurinol Combination Study
Status: Active, not recruiting Condition: Gout

Courtesy of
See more clinical trials for this drug
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
TABLET;ORAL018785Sep 28, 1984DISCNNo<disabled><disabled>
Mylan Institutional
allopurinol sodium
INJECTABLE;INJECTION020298May 17, 1996RXYes<disabled><disabled>
TABLET;ORAL070268Dec 31, 1985DISCNNo<disabled><disabled>
TABLET;ORAL070951Nov 30, 1988DISCNNo<disabled><disabled>
Prometheus Labs
TABLET;ORAL016084Approved Prior to Jan 1, 1982RXNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology